Implications of Genomics for Public Health Workshop Summary (2005) / Chapter Skim
Currently Skimming:
3 Priorities
3 Priorities
Pages 61-68
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 61... ...
Despite the vast promise of public health genomics, there is still much that must be understood before key strategies can be implemented. Our understanding of the science of genomics is incomplete, and a great deal of data gathering, statistical assessment, and research is necessary to assess the interrelationships among genes, the environment, behavior, and population health.
|
From page 62... ...
After the conclusion of the workshop, committee members met to discuss each presentation and commentary and to identify and prioritize issues and approaches explored during the conference. The following presents the committee's deliberations and conclusions.1 The committee agreed that it is of primary importance to develop a coherent understanding of the scientific literature on genetics and its application to public health and health care.
|
From page 63... ...
Ideally, such evaluation would take place prior to the full use of interventions in the health care and public health systems. Evaluation of the literature would also illuminate data gaps and the kinds of research that need to be conducted.
|
From page 64... ...
Therefore, it is vitally important to conduct research on the interactions of these factors and their impacts on health. The results of such research would enable health care and public health practitioners to better support behavior change toward improved health outcomes.
|
From page 65... ...
Change is also needed in the ways in which public health interventions and health information messages are delivered. Translational models must be developed and tested for delivering genomic information to public health practitioners, health care providers, and the public.
|
From page 66... ...
Targeted and perhaps more limited use of drugs suggests new possibilities for cost savings and avoidance of drug drug interactions and adverse drug reactions. It also raises the problem of generating adequate revenue to invest in expensive development of pharmacologic agents that are targeted at small populations.
|
From page 67... ...
PRIORITIES 67 lenge to public health genomics is to overcome inequitable allocation of benefits, the tragedy that would befall us if we made the promise of genetics only for those who could afford it and not for all of society. Social evolution as a result of genomics will be what we want it to be, and now is the time to make our case."
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.